In contrast to the above, there are several reports suggesting FUNDC1 could inhibit carcinogenesis by inducing mitophagy, and could display protective roles in hepatocellular carcinoma [207], laryngeal cancers [208], ovarian cancers, bladder cancers and lung cancers [206]. This evidence concerns the gene FUNDC1 and hepatocellular carcinoma.